Showing results (71-80 of 250) with videos related to
Sort By:
Pageof 25
Biotechnology and Bioengineering|October 5, 1992
Ethanol production from eucalyptus wood hemicellulose hydrolysate by Pichia stipitisM D Ferrari, E Neirotti, C Albornoz, et al.Clinical Pharmacology and Therapeutics|November 7, 2008
Are migraineurs at increased risk of adverse drug responses? A meta-analytic comparison of topiramate-related adverse drug reactions in epilepsy and migraineJ Luykx, M Mason, M D Ferrari, et al.Neurology|August 17, 1999
The prevalence and characteristics of migraine in a population-based cohort: the GEM studyL J Launer, G M Terwindt, M D FerrariStroke|September 1, 1993
Lack of asymmetry of middle cerebral artery blood velocity in unilateral migraineC P Zwetsloot, J F Caekebeke, M D FerrariMicrobiologia (Madrid, Spain)|April 1, 1992
Effect of aeration rate on the alcoholic fermentation of whey by Kluyveromyces fragilisH Varela, M D Ferrari, L Loperena, et al.Neurology|November 19, 2008
Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trialJ J Sevigny, J M Ryan, C H van Dyck, et al.Cephalalgia : an International Journal of Headache|May 24, 2008
Evaluation and registration of adverse events in clinical drug trials in migraineP Tfelt-Hansen, N H Bjarnason, C Dahlöf, et al.Nederlands Tijdschrift Voor Geneeskunde|October 13, 2007
[Migraine and cardiovascular risk]G M Terwindt, J Haan, H Koppen, et al.Nederlands Tijdschrift Voor Geneeskunde|August 12, 2020
[Cluster headache and other trigeminal autonomic cephalalgias]R B Brandt, J Haan, M D Ferrari, et al.Nederlands Tijdschrift Voor Geneeskunde|March 22, 2001
[From gene to disease; from Notch3 to cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy]S A Oberstein, E Bakker, M D Ferrari, et al.Pageof 25